MPP invites Expressions of Interest (EoI) from potential sublicensees based anywhere in the world for sublicences to manufacture and sell the cabotegravir long-acting injectable in the licensed territory.
GENEVA, SWITZERLAND / AGILITYPR.NEWS / May 20, 2022 / The Union for International Cancer Control (UICC) and multiple partners* are establishing the Access to Oncology Medicines (ATOM) Coalition, a new global partnership to increase access to quality-assured essential cancer medicines in low- and lower middle-income countries (LLMICs) and to help countries develop the capacity for their proper use.
The newly established IGBA CEO Advisory Committee, a forum for generic and biosimilar medicines industry leaders to discuss broad, strategic issues, and to engage and position the industry on a range of critical policy matters, held its inaugural meeting on Monday, May 2 and launched initial discussions with World Trade Organization (WTO) Director-General Dr. Ngozi Okonjo-Iweala.
- IGBA establishes a CEO Advisory Committee (February 2022, Committee updated)
- Generics Industry At The Forefront In War Against COVID-19 In 2021: Generics Bulletin (informa.com) (January 2022)
- GENEZIS, the Serbian and Montenegrin Generic and Biosimilar Medicines Association, joins IGBA (January 2022)
- Vivian Frittelli takes over the position of IGBA Chair (January 2022)
